Evidence map›Paper›PMID 42831012›Full record

ReviewClinical ophthalmology (Auckland, N.Z.)2026

ICU-Associated Exposure Keratopathy and Preventable Corneal Blindness: A Clinical Review.

Abdullahi Abdirahman Omar

Abstract readReview
In one paragraph

Review in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Abdullahi Abdirahman OmarDepartment of Ophthalmology, Dr. Sumait Hospital, SIMAD University, Mogadishu, Somalia.ORCID 0000-0003-3295-8339

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exposure keratopathy is an ocular surface injury caused by prolonged corneal exposure, most often from incomplete eyelid closure. Critical illness can intensify exposure through reduced blinking, chemosis, impaired corneal reflexes, sedation, mechanical ventilation, and tear film instability. This narrative clinical review synthesizes contemporary evidence on epidemiology, mechanisms, risk factors, bedside assessment, prevention, protocol implementation, and care in resource-constrained intensive care units (ICUs). PubMed/MEDLINE was searched for English language literature from January 2000 through 15 September 2026, supplemented by reference list and guideline searches. Systematic reviews, randomized trials, cohort studies, quality improvement reports, and relevant guidance were prioritized. Pooled evidence indicates that exposure keratopathy is common among critically ill patients, and recent trials support scheduled lubrication, eyelid closure support, and moisture chamber approaches, particularly when the cornea remains exposed. Fluorescein assessment and clear ophthalmology referral criteria improve detection of epithelial injury and complications that threaten vision. The review distinguishes evidence from randomized and observational studies and proposes a pragmatic bedside risk framework without presenting it as a validated score. Its principal contribution is the integration of prevention, nursing workflow, clinical escalation, and resource appropriate implementation into a single ophthalmic patient safety framework. The intended audience is ophthalmologists, intensivists, ICU nurses, optometrists, and quality improvement teams. Early structured eye care may reduce avoidable corneal morbidity while supporting consistent practice across settings with different resources.

Indexed as

critical carefluorescein stainingocular surface diseasepatient safetyquality improvementresource-constrained settings

Identifiers

PMID42831012
PMCPMC13634232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.